Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QA50
Term | Name | Level | Count |
---|---|---|---|
GO:0001510 | RNA methylation | 4 | 2 |
GO:0002097 | tRNA wobble base modification | 7 | 2 |
GO:0002098 | tRNA wobble uridine modification | 8 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006399 | tRNA metabolic process | 7 | 2 |
GO:0006400 | tRNA modification | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008033 | tRNA processing | 8 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009451 | RNA modification | 5 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0030488 | tRNA methylation | 5 | 2 |
GO:0032259 | methylation | 2 | 2 |
GO:0034470 | ncRNA processing | 7 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034660 | ncRNA metabolic process | 6 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043412 | macromolecule modification | 4 | 2 |
GO:0043414 | macromolecule methylation | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 12 |
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0003723 | RNA binding | 4 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0005525 | GTP binding | 5 | 12 |
GO:0017076 | purine nucleotide binding | 4 | 12 |
GO:0019001 | guanyl nucleotide binding | 5 | 12 |
GO:0032553 | ribonucleotide binding | 3 | 12 |
GO:0032555 | purine ribonucleotide binding | 4 | 12 |
GO:0032561 | guanyl ribonucleotide binding | 5 | 12 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 12 |
GO:0036094 | small molecule binding | 2 | 12 |
GO:0043167 | ion binding | 2 | 12 |
GO:0043168 | anion binding | 3 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:0097367 | carbohydrate derivative binding | 2 | 12 |
GO:1901265 | nucleoside phosphate binding | 3 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 95 | 99 | PF00656 | 0.622 |
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.565 |
CLV_NRD_NRD_1 | 219 | 221 | PF00675 | 0.278 |
CLV_NRD_NRD_1 | 263 | 265 | PF00675 | 0.424 |
CLV_NRD_NRD_1 | 339 | 341 | PF00675 | 0.600 |
CLV_NRD_NRD_1 | 379 | 381 | PF00675 | 0.526 |
CLV_NRD_NRD_1 | 79 | 81 | PF00675 | 0.547 |
CLV_PCSK_FUR_1 | 217 | 221 | PF00082 | 0.362 |
CLV_PCSK_KEX2_1 | 102 | 104 | PF00082 | 0.571 |
CLV_PCSK_KEX2_1 | 111 | 113 | PF00082 | 0.500 |
CLV_PCSK_KEX2_1 | 219 | 221 | PF00082 | 0.272 |
CLV_PCSK_KEX2_1 | 263 | 265 | PF00082 | 0.479 |
CLV_PCSK_KEX2_1 | 339 | 341 | PF00082 | 0.600 |
CLV_PCSK_KEX2_1 | 78 | 80 | PF00082 | 0.553 |
CLV_PCSK_PC1ET2_1 | 102 | 104 | PF00082 | 0.630 |
CLV_PCSK_SKI1_1 | 154 | 158 | PF00082 | 0.310 |
CLV_PCSK_SKI1_1 | 340 | 344 | PF00082 | 0.528 |
CLV_PCSK_SKI1_1 | 428 | 432 | PF00082 | 0.406 |
CLV_PCSK_SKI1_1 | 63 | 67 | PF00082 | 0.615 |
CLV_Separin_Metazoa | 260 | 264 | PF03568 | 0.528 |
CLV_Separin_Metazoa | 353 | 357 | PF03568 | 0.408 |
DEG_APCC_DBOX_1 | 294 | 302 | PF00400 | 0.509 |
DOC_CKS1_1 | 205 | 210 | PF01111 | 0.476 |
DOC_CKS1_1 | 282 | 287 | PF01111 | 0.451 |
DOC_CYCLIN_yCln2_LP_2 | 241 | 247 | PF00134 | 0.401 |
DOC_MAPK_MEF2A_6 | 268 | 276 | PF00069 | 0.389 |
DOC_PP1_RVXF_1 | 152 | 158 | PF00149 | 0.359 |
DOC_PP1_RVXF_1 | 286 | 293 | PF00149 | 0.428 |
DOC_PP1_RVXF_1 | 372 | 379 | PF00149 | 0.428 |
DOC_PP2B_LxvP_1 | 241 | 244 | PF13499 | 0.363 |
DOC_PP2B_LxvP_1 | 301 | 304 | PF13499 | 0.503 |
DOC_PP2B_LxvP_1 | 345 | 348 | PF13499 | 0.566 |
DOC_PP4_FxxP_1 | 157 | 160 | PF00568 | 0.537 |
DOC_PP4_FxxP_1 | 394 | 397 | PF00568 | 0.427 |
DOC_PP4_FxxP_1 | 434 | 437 | PF00568 | 0.437 |
DOC_USP7_MATH_1 | 137 | 141 | PF00917 | 0.656 |
DOC_USP7_UBL2_3 | 188 | 192 | PF12436 | 0.501 |
DOC_WW_Pin1_4 | 10 | 15 | PF00397 | 0.496 |
DOC_WW_Pin1_4 | 111 | 116 | PF00397 | 0.529 |
DOC_WW_Pin1_4 | 204 | 209 | PF00397 | 0.476 |
DOC_WW_Pin1_4 | 281 | 286 | PF00397 | 0.453 |
LIG_14-3-3_CanoR_1 | 133 | 141 | PF00244 | 0.676 |
LIG_14-3-3_CanoR_1 | 356 | 360 | PF00244 | 0.502 |
LIG_14-3-3_CanoR_1 | 72 | 76 | PF00244 | 0.587 |
LIG_14-3-3_CanoR_1 | 84 | 89 | PF00244 | 0.545 |
LIG_Clathr_ClatBox_1 | 202 | 206 | PF01394 | 0.487 |
LIG_FHA_1 | 10 | 16 | PF00498 | 0.495 |
LIG_FHA_1 | 164 | 170 | PF00498 | 0.496 |
LIG_FHA_1 | 189 | 195 | PF00498 | 0.494 |
LIG_FHA_1 | 198 | 204 | PF00498 | 0.457 |
LIG_FHA_1 | 205 | 211 | PF00498 | 0.435 |
LIG_FHA_1 | 213 | 219 | PF00498 | 0.463 |
LIG_FHA_1 | 257 | 263 | PF00498 | 0.559 |
LIG_FHA_1 | 306 | 312 | PF00498 | 0.518 |
LIG_FHA_1 | 38 | 44 | PF00498 | 0.550 |
LIG_FHA_1 | 383 | 389 | PF00498 | 0.420 |
LIG_FHA_1 | 64 | 70 | PF00498 | 0.656 |
LIG_FHA_2 | 112 | 118 | PF00498 | 0.530 |
LIG_FHA_2 | 194 | 200 | PF00498 | 0.560 |
LIG_FHA_2 | 275 | 281 | PF00498 | 0.396 |
LIG_FHA_2 | 294 | 300 | PF00498 | 0.417 |
LIG_FHA_2 | 356 | 362 | PF00498 | 0.482 |
LIG_FHA_2 | 377 | 383 | PF00498 | 0.446 |
LIG_FHA_2 | 416 | 422 | PF00498 | 0.521 |
LIG_LIR_Apic_2 | 391 | 397 | PF02991 | 0.413 |
LIG_LIR_Gen_1 | 358 | 367 | PF02991 | 0.522 |
LIG_LIR_LC3C_4 | 236 | 240 | PF02991 | 0.536 |
LIG_LIR_Nem_3 | 110 | 116 | PF02991 | 0.520 |
LIG_LIR_Nem_3 | 117 | 123 | PF02991 | 0.518 |
LIG_LIR_Nem_3 | 358 | 362 | PF02991 | 0.510 |
LIG_LIR_Nem_3 | 402 | 407 | PF02991 | 0.416 |
LIG_LIR_Nem_3 | 61 | 65 | PF02991 | 0.604 |
LIG_Pex14_2 | 427 | 431 | PF04695 | 0.469 |
LIG_REV1ctd_RIR_1 | 391 | 396 | PF16727 | 0.408 |
LIG_SH2_CRK | 230 | 234 | PF00017 | 0.562 |
LIG_SH2_CRK | 329 | 333 | PF00017 | 0.421 |
LIG_SH2_CRK | 62 | 66 | PF00017 | 0.477 |
LIG_SH2_NCK_1 | 113 | 117 | PF00017 | 0.538 |
LIG_SH2_NCK_1 | 329 | 333 | PF00017 | 0.421 |
LIG_SH2_STAP1 | 230 | 234 | PF00017 | 0.562 |
LIG_SH2_STAP1 | 35 | 39 | PF00017 | 0.512 |
LIG_SH2_STAT5 | 113 | 116 | PF00017 | 0.513 |
LIG_SH2_STAT5 | 291 | 294 | PF00017 | 0.403 |
LIG_SH2_STAT5 | 35 | 38 | PF00017 | 0.513 |
LIG_SH2_STAT5 | 39 | 42 | PF00017 | 0.500 |
LIG_SH3_3 | 141 | 147 | PF00018 | 0.508 |
LIG_SH3_3 | 279 | 285 | PF00018 | 0.440 |
LIG_SH3_3 | 48 | 54 | PF00018 | 0.471 |
LIG_SUMO_SIM_anti_2 | 199 | 207 | PF11976 | 0.503 |
LIG_SUMO_SIM_anti_2 | 236 | 242 | PF11976 | 0.487 |
LIG_SUMO_SIM_par_1 | 199 | 207 | PF11976 | 0.490 |
LIG_SUMO_SIM_par_1 | 317 | 324 | PF11976 | 0.408 |
LIG_SUMO_SIM_par_1 | 84 | 91 | PF11976 | 0.682 |
LIG_TRAF2_1 | 115 | 118 | PF00917 | 0.534 |
LIG_WRC_WIRS_1 | 400 | 405 | PF05994 | 0.412 |
MOD_CDK_SPxxK_3 | 281 | 288 | PF00069 | 0.454 |
MOD_CK1_1 | 10 | 16 | PF00069 | 0.523 |
MOD_CK1_1 | 140 | 146 | PF00069 | 0.593 |
MOD_CK1_1 | 383 | 389 | PF00069 | 0.439 |
MOD_CK1_1 | 74 | 80 | PF00069 | 0.560 |
MOD_CK1_1 | 87 | 93 | PF00069 | 0.525 |
MOD_CK2_1 | 111 | 117 | PF00069 | 0.516 |
MOD_CK2_1 | 193 | 199 | PF00069 | 0.588 |
MOD_CK2_1 | 293 | 299 | PF00069 | 0.411 |
MOD_CK2_1 | 355 | 361 | PF00069 | 0.508 |
MOD_CK2_1 | 376 | 382 | PF00069 | 0.529 |
MOD_CK2_1 | 415 | 421 | PF00069 | 0.513 |
MOD_GlcNHglycan | 134 | 137 | PF01048 | 0.668 |
MOD_GlcNHglycan | 223 | 226 | PF01048 | 0.305 |
MOD_GlcNHglycan | 316 | 319 | PF01048 | 0.507 |
MOD_GlcNHglycan | 382 | 385 | PF01048 | 0.471 |
MOD_GSK3_1 | 164 | 171 | PF00069 | 0.501 |
MOD_GSK3_1 | 17 | 24 | PF00069 | 0.484 |
MOD_GSK3_1 | 184 | 191 | PF00069 | 0.345 |
MOD_GSK3_1 | 193 | 200 | PF00069 | 0.449 |
MOD_GSK3_1 | 25 | 32 | PF00069 | 0.475 |
MOD_GSK3_1 | 293 | 300 | PF00069 | 0.416 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.514 |
MOD_GSK3_1 | 305 | 312 | PF00069 | 0.421 |
MOD_GSK3_1 | 33 | 40 | PF00069 | 0.463 |
MOD_GSK3_1 | 376 | 383 | PF00069 | 0.463 |
MOD_NEK2_1 | 132 | 137 | PF00069 | 0.711 |
MOD_NEK2_1 | 168 | 173 | PF00069 | 0.494 |
MOD_NEK2_1 | 355 | 360 | PF00069 | 0.472 |
MOD_NEK2_1 | 376 | 381 | PF00069 | 0.548 |
MOD_NEK2_1 | 58 | 63 | PF00069 | 0.562 |
MOD_NEK2_1 | 65 | 70 | PF00069 | 0.539 |
MOD_NEK2_1 | 9 | 14 | PF00069 | 0.458 |
MOD_NEK2_2 | 193 | 198 | PF00069 | 0.476 |
MOD_NEK2_2 | 399 | 404 | PF00069 | 0.400 |
MOD_PIKK_1 | 197 | 203 | PF00454 | 0.476 |
MOD_PIKK_1 | 212 | 218 | PF00454 | 0.476 |
MOD_PK_1 | 84 | 90 | PF00069 | 0.575 |
MOD_PKA_1 | 380 | 386 | PF00069 | 0.458 |
MOD_PKA_2 | 132 | 138 | PF00069 | 0.640 |
MOD_PKA_2 | 212 | 218 | PF00069 | 0.538 |
MOD_PKA_2 | 355 | 361 | PF00069 | 0.434 |
MOD_PKA_2 | 71 | 77 | PF00069 | 0.632 |
MOD_Plk_1 | 309 | 315 | PF00069 | 0.446 |
MOD_Plk_4 | 164 | 170 | PF00069 | 0.488 |
MOD_Plk_4 | 274 | 280 | PF00069 | 0.507 |
MOD_Plk_4 | 355 | 361 | PF00069 | 0.508 |
MOD_Plk_4 | 84 | 90 | PF00069 | 0.601 |
MOD_ProDKin_1 | 10 | 16 | PF00069 | 0.495 |
MOD_ProDKin_1 | 111 | 117 | PF00069 | 0.531 |
MOD_ProDKin_1 | 204 | 210 | PF00069 | 0.476 |
MOD_ProDKin_1 | 281 | 287 | PF00069 | 0.452 |
MOD_SUMO_rev_2 | 251 | 257 | PF00179 | 0.426 |
TRG_DiLeu_BaEn_1 | 199 | 204 | PF01217 | 0.414 |
TRG_ENDOCYTIC_2 | 113 | 116 | PF00928 | 0.521 |
TRG_ENDOCYTIC_2 | 230 | 233 | PF00928 | 0.562 |
TRG_ENDOCYTIC_2 | 291 | 294 | PF00928 | 0.403 |
TRG_ENDOCYTIC_2 | 404 | 407 | PF00928 | 0.411 |
TRG_ENDOCYTIC_2 | 62 | 65 | PF00928 | 0.483 |
TRG_ER_diArg_1 | 111 | 113 | PF00400 | 0.565 |
TRG_ER_diArg_1 | 217 | 220 | PF00400 | 0.481 |
TRG_ER_diArg_1 | 262 | 264 | PF00400 | 0.537 |
TRG_ER_diArg_1 | 338 | 340 | PF00400 | 0.601 |
TRG_ER_diArg_1 | 371 | 374 | PF00400 | 0.421 |
TRG_ER_diArg_1 | 78 | 80 | PF00400 | 0.557 |
TRG_NES_CRM1_1 | 269 | 280 | PF08389 | 0.511 |
TRG_Pf-PMV_PEXEL_1 | 420 | 425 | PF00026 | 0.557 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PER9 | Leptomonas seymouri | 82% | 100% |
A0A0S4IU66 | Bodo saltans | 49% | 100% |
A0A1X0P4I4 | Trypanosomatidae | 64% | 100% |
A0A3R7NZ49 | Trypanosoma rangeli | 66% | 100% |
A0A3S5H7E2 | Leishmania donovani | 98% | 100% |
A4HDY7 | Leishmania braziliensis | 91% | 100% |
A4I188 | Leishmania infantum | 94% | 91% |
D0A5H3 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 62% | 100% |
E9AXC2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 84% |
V5B7N0 | Trypanosoma cruzi | 64% | 100% |